06.30.2026 Kabuki Syndrome Foundation Announces 2026 Discovery Program to Enable Gene-Targeting Therapies The Kabuki Syndrome Foundation (KSF) is excited to announce the launch of the 2026 Discovery...
06.16.2026 KSF Advisory Boards Meeting Highlights: Shaping the Future of Kabuki Syndrome Research The Kabuki Syndrome Foundation recently convened an Advisory Boards meeting, bringing together 10 medical and...
03.31.2026 KSOC Researchers Meet in Baltimore to Share Progress This March, researchers and advisors from the Kabuki Syndrome Outcome Measures and Biomarkers Consortium (KSOC)...
01.06.2026 Expanded Drug Repurposing Study Now Includes Kabuki Syndrome Type 1 We are excited to share an important update on our drug repurposing study with Unravel...
09.30.2025 Kabuki Syndrome Now Has an ICD-10-CM Code: Q89.81 Starting October 1, 2025, Kabuki syndrome is officially recognized in U.S. medical records with its...
04.19.2024 First KSF Monthly Lab Meeting Hosts Over 25 Researchers On April 9, 2024, Dr. Clara Tang, KSF Director of Research, facilitated the first global...